
Moderna Inc. (NASDAQ:MRNA) shares are trading after the company reported better-than-expected fourth-quarter EPS and sales results and announced a new $3 billion buyback.
Moderna reported quarterly earnings of $11.29 per share, beating the analyst consensus estimate of $9.90. The company reported quarterly sales of $7.20 billion, beating the analyst consensus estimate of $6.79 billion